Lung Cancer Panel 2 EGFR ALK1 ROS1 Test - $562 USD | Comprehensive Genetic Testing for Lung Cancer in USA
Inv(16) AML M4Eo FISH Test - $132 USD in USA | Acute Myeloid Leukemia Genetic Testing Inv(16) AML M4Eo FISH Test Original price was: $176.Current price is: $132.
MET Amplification NSCLC Test - $226 USD | Comprehensive Genetic Testing for Lung Cancer in USA MET Amplification NSCLC Test Original price was: $300.Current price is: $226.
Sale!

Lung Cancer Panel 2: EGFR, ALK1, ROS1

Original price was: $750.Current price is: $562.

-25%

The Lung Cancer Panel 2: EGFR, ALK1, ROS1 is a comprehensive genetic test designed to identify specific mutations in non-small cell lung cancer patients. This advanced diagnostic panel analyzes three critical genetic markers – EGFR, ALK1, and ROS1 – that play pivotal roles in targeted therapy selection. Using sophisticated FISH and Sanger sequencing technologies, the test provides precise mutation detection from tumor tissue samples. Results are typically available within 5-7 days, enabling timely treatment decisions. The test costs $562 USD and requires a doctor’s prescription, except for surgery, pregnancy, or international travel cases. This panel helps oncologists determine the most effective targeted therapies, potentially improving treatment outcomes and quality of life for lung cancer patients.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

Lung Cancer Panel 2: EGFR, ALK1, ROS1 Genetic Testing

Comprehensive Introduction to Lung Cancer Genetic Testing

The Lung Cancer Panel 2 represents a cutting-edge approach to personalized cancer care, specifically designed for patients with non-small cell lung cancer (NSCLC). This comprehensive genetic analysis examines three critical biomarkers – EGFR, ALK1, and ROS1 – that have revolutionized lung cancer treatment strategies. By identifying specific genetic mutations, this test enables oncologists to select targeted therapies that precisely match your cancer’s genetic profile, potentially leading to more effective treatment outcomes with fewer side effects.

What This Advanced Test Measures and Detects

Our Lung Cancer Panel 2 utilizes sophisticated laboratory techniques to identify specific genetic alterations:

  • EGFR Mutations: Detects epidermal growth factor receptor gene mutations that respond to EGFR inhibitor therapies
  • ALK1 Rearrangements: Identifies anaplastic lymphoma kinase gene fusions suitable for ALK inhibitor treatments
  • ROS1 Rearrangements: Screens for ROS1 gene fusions that may benefit from specific targeted medications

The test employs both FISH (Fluorescence In Situ Hybridization) and Sanger sequencing methodologies to ensure comprehensive and accurate mutation detection from paraffin-embedded tumor tissue blocks.

Who Should Consider This Genetic Test

This advanced genetic panel is particularly recommended for individuals experiencing:

  • Newly diagnosed non-small cell lung cancer
  • Advanced or metastatic lung cancer requiring treatment planning
  • Progression after initial lung cancer treatment
  • Family history of lung cancer or genetic predisposition
  • Need for personalized treatment strategy based on genetic markers

Significant Benefits of Genetic Testing

Undergoing the Lung Cancer Panel 2 offers numerous advantages:

  • Personalized Treatment Selection: Identifies the most effective targeted therapies for your specific cancer type
  • Improved Treatment Outcomes: Potential for better response rates and prolonged survival
  • Reduced Side Effects: Targeted therapies often have fewer adverse effects than traditional chemotherapy
  • Informed Decision Making: Provides crucial information for treatment planning and prognosis
  • Comprehensive Analysis: Multiple biomarker testing in a single efficient panel

Understanding Your Test Results

Your test results will provide detailed information about the presence or absence of specific genetic mutations:

  • Positive Results: Indicate the presence of targetable mutations, guiding your oncologist toward specific targeted therapies
  • Negative Results: Help exclude certain treatment options, allowing focus on alternative approaches
  • Interpretive Guidance: Our comprehensive report includes clear explanations and clinical implications
  • Consultation Support: Results are best discussed with your healthcare provider for personalized treatment planning

Test Pricing and Availability

Price Type Amount (USD)
Discount Price $562
Regular Price $750

Nationwide Testing Accessibility

We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our network of certified laboratories ensures consistent, high-quality testing standards nationwide.

Important Pre-Test Information

This genetic test requires a physician’s prescription for most cases. However, prescription requirements do not apply to individuals undergoing surgery, pregnant patients, or those planning international travel. The test utilizes tumor tissue samples with a typical turnaround time of 5-7 days from sample receipt.

Take Action for Personalized Cancer Care

Don’t leave your lung cancer treatment to chance. Our Lung Cancer Panel 2 provides the genetic insights needed for targeted, effective therapy selection. Contact us today to schedule your test and take the first step toward personalized cancer treatment.

Call or WhatsApp: +1(267) 388-9828 to book your comprehensive genetic testing appointment.

SKU: bcb7c13ff974 Category:

Related products